Genomic Medicine Senior Leadership Brazos November 3, 2005 - PowerPoint PPT Presentation

1 / 10
About This Presentation
Title:

Genomic Medicine Senior Leadership Brazos November 3, 2005

Description:

... the drug to cause serious, even fatal, side effects gene testing can lead to ... Driven by the desire to participate in the KOMP (Knock Out Mouse Project) ... – PowerPoint PPT presentation

Number of Views:47
Avg rating:3.0/5.0
Slides: 11
Provided by: offic141
Category:

less

Transcript and Presenter's Notes

Title: Genomic Medicine Senior Leadership Brazos November 3, 2005


1
Genomic MedicineSenior Leadership
BrazosNovember 3, 2005
  • Nancy W. Dickey, MD
  • Roderick E. McCallum, PhD
  • Texas AM Health Science Center

2
Some interesting tidbits
  • We dont know precisely how many genes the genome
    contains but current data indicate that there are
    30,000-35,000 genes
  • Mutations that cause disease have been identified
    in approximately 1000 genes
  • Some chromosomes are gene dense (17, 19, 22) as
    compared to others (4, 8, 13, 18)
  • Only 2 of the human genome codes for proteins
    though through alternative splicing, over 100,000
    proteins can be derived from these genes
  • More than 50 of the human genome represents
    repeat sequences of several types whose function
    is poorly understood
  • A complex array of molecular signals allows
    specific genes to be turned on (expressed) or
    turned off in specific tissues at specific times

3
A few terms
  • Genomic medicine
  • A term coined 15 years ago
  • Study not just of single genes but of the
    functions and interactions of all the genes in
    the genome, the interactions of multiple genes
    and the impact of the environment

4
And more termsgenetics
  • The study of single genes and their effects
  • A genetic test is the analysis of human DNA, RNA,
    or chromosomes for clinical purposes
  • Most available genetic tests address questions
    related to rare or uncommon diseases
  • Genetic tests can be done to diagnose genetic
    disease (often in newborns), identification of
    future health risks, assessment of risks to
    future children
  • Identification of carrier status (recessive)
  • Identification does not necessarily mean
    treatment options Huntingtons Chorea can
    predict with nearly 100 effectiveness but not
    treat (Valley of the Dolls)
  • Genetics for preventive care is emerging but
    remains problematic e.g. BRCA1 and 2 mutations in
    breast and ovarian cancer but lifetime risk
    estimates range from 26-85

5
Terms continued
  • Proteomics
  • Proteins are called by some the machines of
    molecules
  • Proteomics is a variety of things all of which
    are aspects of understanding proteins, their
    spatial structure, cataloguing or mapping their
    structure in particular membranes
  • Proteomics is the study of how proteins are
    modified by enzymes, genetics, chemical
    interactions, etc.
  • Proteomics is the study of protein-protein
    interactions and qualitative and quantitative
    changes arising under a variety of influences

6
Pharmacogenomics
  • Many things influence effects of medications
    including age, organ function, other drugs,
    nature of the disease and genomics
  • There are more than 30 families of
    drug-metabolizing enzymes in humans and
    essentially all have genetic variants
  • ¾ of whites and ½ of blacks have a genetic
    inability to express the CYP3A5 family of P-450
    enzymes
  • If medications are equally metabolized by both
    CYP3A5 and CYP3A4, it is difficult to see the
    problem.
  • For medications metabolized substantially more by
    CYP3A5, the inability to express the enzyme could
    mean problems with some medications
  • Children with acute lymphoblastic leukemia often
    receive mercaptopurine but 1/300 patients has a
    mutation of a gene that can cause the drug to
    cause serious, even fatal, side effects gene
    testing can lead to reduced dosages and fewer
    problems
  • A future is visualized when genetic testing might
    help determine which medication is best for you

7
Dilemma posed by genetics/genomics.
  • Misuse of information to deny access health
    insurance, employment, loans
  • Dilemma of privacy vs. right to know
  • Daughter of man with diffuse adenomatous
    polyposis her right to know vs. his right to
    privacy

8
Texas Institute for Genomic Medicine - TIGM
  • Created by the Governors Enterprise Fund
  • Driven by the desire to participate in the KOMP
    (Knock Out Mouse Project)
  • Approximately 20,000-30,000 genes with more than
    95 similarity to humans
  • Individually knock out each gene creating mice
    missing a particular gene (30,000 different mice!)

9
Genomic Medicine by Mouse
  • Take the mice minus a gene and give them a souped
    up executive physical find out what works
    better or worse or not at all when THAT gene if
    missing
  • Create targets for pharmaceuticals, models to
    understand human disease, and so on

10
TIGM
  • Scientists at Texas AM University and at the AM
    Health Science Center will have exceptional
    opportunity to be at the cutting edge of genomic
    medicine
  • But as you can see from the depiction at the
    right and the numbers throughout none of the
    answers will be available tomorrow
Write a Comment
User Comments (0)
About PowerShow.com